-transparent.png){kind=logo}
The ureidopenicillin piperacillin was given to 20 patients with urinary tract infections. The infecting microbes all had a minimum inhibitory concentration below 0.6 microgram/ml. One strain of Staphylococcus aureus produced beta-lactamase. All patients were freed of their microbes at the end of 7 days therapy. 1--2 weeks after the end of therapy, 1 relapsed and 3 had superinfections. Among the 16 who were without bacteria or leucocyturia after 1--2 weeks, 2 exhibited a superinfection 4--6 weeks after the end of therapy.
Related Publications
S Sander, and
T Bergan, and
E Fossberg
July 1994,
Intensive care medicine,
S Sander, and
T Bergan, and
E Fossberg
January 1981,
The Medical journal of Australia,
S Sander, and
T Bergan, and
E Fossberg
January 1981,
Giornale italiano di chemioterapia,
S Sander, and
T Bergan, and
E Fossberg
May 1986,
The Journal of antimicrobial chemotherapy,
S Sander, and
T Bergan, and
E Fossberg
March 1986,
La Clinica terapeutica,
S Sander, and
T Bergan, and
E Fossberg
November 1990,
The Journal of antimicrobial chemotherapy,
S Sander, and
T Bergan, and
E Fossberg
May 1987,
Urology,
S Sander, and
T Bergan, and
E Fossberg
November 1985,
The American journal of medicine,
S Sander, and
T Bergan, and
E Fossberg
January 1986,
Hinyokika kiyo. Acta urologica Japonica,
S Sander, and
T Bergan, and
E Fossberg
September 1988,
Hinyokika kiyo. Acta urologica Japonica,
